(Q42717496)

English

Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment

scientific article published on 13 June 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

Fang-Wei Hu

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Lo-Lin Tsai

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Chuan-Hang Yu

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Pei-Ni Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Ming-Yung Chou

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Cheng-Chia Yu

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

13 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Molecular Nutrition and Food Research

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

1247-1258

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

The epithelial-mesenchymal transition generates cells with properties of stem cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Resveratrol and health--a comprehensive review of human clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Cancer stem cells: mirage or reality?

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

The increasing complexity of the cancer stem cell paradigm

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

The basics of epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Identification of selective inhibitors of cancer stem cells by high-throughput screening

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Targeting breast stem cells with the cancer preventive compounds curcumin and piperine

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

MicroRNA regulation of cancer stem cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

let-7 regulates self renewal and tumorigenicity of breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200150

21 January 2018

Identifiers

10.1002/MNFR.201200150

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42717496&oldid=1967109391"